Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02062827 |
|---|---|
| Brief Title: | Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (M032-HSV-1) |
| First Submitted : | February 9, 2014 |
| First Submitted that Met QC Criteria : | February 12, 2014 |
| First Posted : | February 14, 2014 (Estimate) |
| Results First Submitted : | October 5, 2023 |
| Results First Submitted that Met QC Criteria : | February 1, 2024 |
| Results First Posted : | February 2, 2024 |
| Last Update Submitted that Met QC Criteria : | February 1, 2024 |
| Last Update Posted : | February 2, 2024 |